2022 ICD-10-CM Diagnosis Code C77.9
Toggle navigation
Search All ICD-10 Toggle Dropdown
- Search All ICD-10
- ICD-10-CM Diagnosis Codes
- ICD-10-PCS Procedure Codes
- ICD-10-CM Diagnosis Index
- ICD-10-CM External Causes Index
- ICD-10-CM Table of Drugs
- ICD-10-CM Table of Neoplasms
- HCPCS Codes
- ICD-9-CM Diagnosis Codes
- ICD-9-Vol-3 Procedure Code
- Search All Data
2026
- ICD-10-CM Codes ›
- C00-D49 ›
- C76-C80 ›
- C77- ›
- 2026 ICD-10-CM Diagnosis Code C77.9
Secondary and unspecified malignant neoplasm of lymph node, unspecified
- 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Billable/Specific Code
- C77.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- Short description: Secondary and unsp malignant neoplasm of lymph node, unsp
- The 2026 edition of ICD-10-CM C77.9 became effective on October 1, 2025.
- This is the American ICD-10-CM version of C77.9 - other international versions of ICD-10 C77.9 may differ.
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
- C00-D49 2026 ICD-10-CM Range C00-D49
NeoplasmsNote
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
- C77 ICD-10-CM Diagnosis Code C77
Secondary and unspecified malignant neoplasm of lymph nodes
- 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Non-Billable/Non-Specific Code
- malignant neoplasm of lymph nodes, specified as primary (C81-C86, C88, C96.-)
- mesentery metastasis of carcinoid tumor (C7B.04)
- secondary carcinoid tumors of distant lymph nodes (C7B.01)
- Breast cancer metastatic to lymph node
- Cancer metastatic to lymph node, adenocarcinoma
- Cancer metastatic to lymph node, small cell
- Cancer metastatic to lymph node, squamous cell
- Cancer metastatic to lymph nodes
- Cancer metastatic to lymph nodes undiffer lg cell
- Female breast cancer metastatic to lymph node
- Male breast cancer metastatic to lymph node
- Melanoma eye, metastatic to lung
- Melanoma, metastatic to lymph node
- Metastasis to lymph node from adenocarcinoma
- Metastasis to lymph node from squamous cell carcinoma
- Secondary adenocarcinoma of lymph node
- Secondary malignant melanoma of lung from eye
- Secondary malignant melanoma of lymph node
- Secondary malignant neoplasm of lymph node
- Secondary malignant neoplasm of lymph node from neoplasm of breast
- Secondary malignant neoplasm of lymph node from neoplasm of female breast
- Secondary malignant neoplasm of lymph node from neoplasm of male breast
- Secondary small cell cancer of lymph node
- Secondary squamous cell carcinoma of lymph node
- Secondary undifferentiated large cell malignant neoplasm of lymph node
- The spread of cancer to and establishment in the lymph nodes
- 820 Lymphoma and leukemia with major o.r. Procedures with mcc
- 821 Lymphoma and leukemia with major o.r. Procedures with cc
- 822 Lymphoma and leukemia with major o.r. Procedures without cc/mcc
- 823 Lymphoma and non-acute leukemia with other procedures with mcc
- 824 Lymphoma and non-acute leukemia with other procedures with cc
- 825 Lymphoma and non-acute leukemia with other procedures without cc/mcc
- 840 Lymphoma and non-acute leukemia with mcc
- 841 Lymphoma and non-acute leukemia with cc
- 842 Lymphoma and non-acute leukemia without cc/mcc
Convert C77.9 to ICD-9-CM
Code History- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
- 2025 (effective 10/1/2024): No change
- 2026 (effective 10/1/2025): No change
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Advertise with Us | License ICD10 Data | Medical billing and coding classes
Copyright © | ICD10data.com
Từ khóa » C77.9 G
-
C77.9 Sekundäre Und Nicht Näher Bezeichnete Bösartige Neubildung
-
ICD-10-Code: C77 Sekundäre Und Nicht Näher Bezeichnete ...
-
[PDF] Korrektes Kodieren In Der Praxis: Karzinome Und Metastasierungen
-
C77.- Sekundäre Und Nicht Näher Bezeichnete Bösartige ... - ICD-10
-
[PDF] ICD - O International Classification Of Diseases For Oncology
-
42 CFR § 81.23 - Guidelines For Cancers For Which Primary Site Is ...
-
ICD C77.9 - Sekundäre Und Nicht Näher Bezeichnete Bösartige ...
-
Kapitel II Neubildungen (C00-D48) - DIMDI - ICD-10-GM Version 2019
-
ICD-10-GM 2021: C77.9 Sekundäre Und Nicht Näher Bezeichnete ...
-
42 CFR 81.23 -- Guidelines For Cancers For Which Primary Site Is ...
-
Lymphoma In The Tofacitinib Rheumatoid Arthritis Clinical ... - NCBI
-
[PDF] Coding & Reimbursement
-
[PDF] Coding Primary Site And Tumor Morphology